https://www.benzinga.com/insights/analyst-ratings/24/11/42167882/tg-therapeutics-stock-a-deep-dive-into-analyst-perspectives-5-ratings
TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - TG Therapeutics...
a deep diveanalyst perspectivestgtherapeuticsstock
https://investingnews.com/daily/life-science-investing/biotech-investing/tg-therapeutics-announces-long-term-follow-up-data-from-the-phase-2-trial-of-ublituximab-in-patients-with-multiple-sclerosis/
TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in...
Jan 3, 2026 - TG Therapeutics (NASDAQ:TGTX) has announced presentation of long-term follow-up data of its Phase 2 open label extension trial of ubiltuximab (TG-1101) the...
https://www.benzinga.com/news/24/08/40194925/yum-china-posts-upbeat-earnings-joins-clear-secure-tg-therapeutics-bioventus-and-other-big-stocks-mo
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big...
https://www.benzinga.com/insights/options/24/11/42118717/a-closer-look-at-tg-therapeuticss-options-market-dynamics
A Closer Look at TG Therapeutics's Options Market Dynamics - TG Therapeutics (NASDAQ:TGTX) -...
a closer look at
https://stockanalysis.com/quote/bit/1TGTX/
TG Therapeutics (BIT:1TGTX) Stock Price & Overview
Get the latest TG Therapeutics, Inc. (BIT:1TGTX) stock price quote with financials, statistics, dividends, charts, historical data and more.
stock pricetgtherapeuticsbitoverview
https://finviz.com/news/344705/tg-therapeutics-announces-completion-of-enrollment-for-the-phase-3-trial-evaluating-subcutaneous-briumvi
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous...
Stock screener for investors and traders, financial visualizations.
https://www.fool.com/investing/2025/05/05/why-tg-therapeutics-stock-was-tumbling-today/
Why TG Therapeutics Stock Was Tumbling Today | The Motley Fool
May 5, 2025 - Why TG Therapeutics Stock Was Tumbling Today
the motleytgtherapeuticsstocktumbling
https://www.plus500.com/en-ae/instruments/tgtx
TG Therapeutics (TGTX) CFDs
Track the latest TG Therapeutics stock price at 39.31 with a -0.10% daily change (indicative prices). Buy/sell TG Therapeutics (TGTX) share CFDs.
tgtherapeuticscfds
https://www.mql5.com/en/quotes/stocks/tgtx
TGTX (TG Therapeutics Inc): Stock Prices, Quotes & Online Live Charts
TGTX exchange rate has changed by -0.40% for today. During the day, the instrument was traded at a low of 42.26 and at a high of 44.65
stock pricesonline livetgtherapeuticsinc
https://www.prnewswire.com/news-releases/tg-therapeutics-tgtx-alert-johnson-fistel-investigates-tg-therapeutics-inc-investors-encouraged-to-contact-the-firm-300719000.html
TG Therapeutics (TGTX) Alert: Johnson Fistel Investigates TG Therapeutics, Inc.; Investors...
/PRNewswire/ -- Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential claims on behalf of investors of TG Therapeutics, Inc....
tgtherapeuticsalertjohnsonfistel
https://www.sofi.com/invest/stock/TGTX/
Buy TG Therapeutics Stock - TGTX Stock Price, Quote & News | SoFi
See real time price charts for TGTX stock, historical data, and recent news. Buy TGTX stock online with no commission fees.
price quotebuytgtherapeuticsstock
https://www.ig.com/en/shares/markets-shares/tg-therapeutics-inc
Trade TG Therapeutics Inc Shares | TG Therapeutics Inc Share Price | TG Therapeutics Inc | IG...
TG Therapeutics, Inc. is a fully integrated, commercial stage biotechnology company focused on the acquisition, development and commercialization... [EN]
share pricetradetgtherapeuticsinc
https://www.fool.com/investing/2018/09/25/a-big-disappointment-sends-tg-therapeutics-stock-s.aspx
A Big Disappointment Sends TG Therapeutics Stock Skidding 34% Today | The Motley Fool
Sep 25, 2018 - The company's pathway to the FDA just got a bit bumpier.
https://www.biospace.com/tg-therapeutics-provides-business-update-and-reports-third-quarter-2020-financial-results
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results - BioSpace
Nov 9, 2020 - TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2020 and recent company developments....
https://www.biospace.com/press-releases/tg-therapeutics-announces-data-presentations-for-briumvi-in-multiple-sclerosis-at-the-american-academy-of-neurology-2025-annual-meeting
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American...
https://www.plus500.com/en-hr/instruments/tgtx
TG Therapeutics (TGTX) CFDs
Track the latest TG Therapeutics stock price at 42.72 with a -0.33% daily change (indicative prices). Buy/sell TG Therapeutics (TGTX) share CFDs.
tgtherapeuticscfds
https://finviz.com/quote?t=TGTX&ta=1&p=d&ty=tr
TGTX - TG Therapeutics Inc Website Traffic and Mobile Apps Usage
TGTX - TG Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
website trafficmobile appstgtherapeuticsinc
https://finviz.com/quote?t=TGTX&ty=si
TGTX - TG Therapeutics Inc Short Interest
TGTX - TG Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
tgtherapeuticsincshortinterest
https://www.macrotrends.net/stocks/charts/TGTX/tg-therapeutics/net-profit-margin
TG Therapeutics Net Profit Margin 2012-2026 | TGTX | MacroTrends
Current and historical net profit margin for TG Therapeutics (TGTX) from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total...
net profit margintgtherapeutics20122026
https://finviz.com/news/333042/bank-of-america-securities-bearish-on-tg-therapeutics-tgtx-post-earnings
Bank of America Securities Bearish on TG Therapeutics (TGTX) Post Earnings
Stock screener for investors and traders, financial visualizations.
bank of america securitiesbearish
https://finviz.com/quote?t=TGTX&ty=ea
TGTX - TG Therapeutics Inc Earnings
TGTX - TG Therapeutics Inc - Stock screener for investors and traders, financial visualizations.
tgtherapeuticsincearnings
https://www.plus500.com/en-nl/instruments/tgtx
TG Therapeutics (TGTX) CFDs
Track the latest TG Therapeutics stock price at 39.35 with a -3.16% daily change (indicative prices). Buy/sell TG Therapeutics (TGTX) share CFDs.
tgtherapeuticscfds